REFERENCES
- Sever MS, Erek E, Vanholder R, et al. Lessons learned from the catastrophic Marmara earthquake: Factors influencing the final outcome of renal victims. Clin Nephrol. 2004; 61: 413–421
- Zager RA. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int. 1996; 49: 314–326
- Abassi ZA, Hoffman A, Better OS. Acute renal failure complicating muscle crush injury. Semin Nephrol. 1998; 18: 558–565
- Paller MS. Hemoglobin- and myoglobin-induced acute renal failure in rats: Role of iron in nephrotoxicity. Am J Physiol. 1988; 255: F539–F544
- Shah SV, Walker PD. Evidence suggesting a role for hydroxyl radical in glycerol-induced acute renal failure. Am J Physiol. 1988; 255: F438–F443
- Zager RA. Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress. Mechanistic and therapeutic implications. J Clin Invest. 1992; 90: 711–719
- Nath KA, Balla G, Vercellotti GM, et al. Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest. 1992; 90: 267–270
- Emerit J, Beaumont C, Trivin F. Iron metabolism, free radicals, and oxidative injury. Biomed Pharmacother. 2001; 55: 333–339
- Paller MS, Hedlund BE. Role of iron in postischemic renal injury in the rat. Kidney Int. 1988; 34: 474–480
- Baliga R, Ueda N, Walker PD, Shah SV. Oxidant mechanisms in toxic acute renal failure. Am J Kidney Dis. 1997; 29: 465–477
- Kanner J, Harel S. Initiation of membranal lipid peroxidation by activated metmyoglobin and methemoglobin. Arch Biochem Biophys. 1985; 237: 314–321
- Galaris D, Korantzopoulos P. On the molecular mechanism of metmyoglobin-catalyzed reduction of hydrogen peroxide by ascorbate. Free Radic Biol Med. 1997; 22: 657–667
- Patel RP, Diczfalusy U, Dzeletovic S, Wilson MT, Darley-Usmar VM. Formation of oxysterols during oxidation of low density lipoprotein by peroxynitrite, myoglobin, and copper. J Lipid Res. 1996; 37: 2361–2371
- Freeman BA, Crapo JD. Biology of disease: Free radicals and tissue injury. Lab Invest. 1982; 47: 412–426
- Nishikimi M. Oxidation of ascorbic acid with superoxide anion generated by the xanthine-xanthine oxidase system. Biochem Biophys Res Commun. 1975; 63: 463–468
- Bielski BH. Chemistry of ascorbic acid radicals. Ascorbic acid: Chemistry, metabolism, and uses. Adv Chem Ser. 1982; 200: 81–100
- Bodannes RS, Chan PC. Ascorbic acid as a scavenger of singlet oxygen. FEBS Lett. 1979; 105: 195–196
- Frei B, Stocker R, England L, Ames BN. Ascorbate: The most effective antioxidant in human blood plasma. Adv Exp Med Biol. 1990; 264: 155–163
- Abraham P. Vitamin C may be beneficial in the prevention of paracetamol-induced renal damage. Clin Exp Nephrol. 2005; 9: 24–30
- Kavutcu M, Canbolat O, Oztürk S, et al. Reduced enzymatic antioxidant defense mechanism in kidney tissues from gentamicin-treated guinea pigs: Effects of vitamins E and C. Nephron. 1996; 72: 269–274
- Singh S, Rana SV. Amelioration of arsenic toxicity by L-Ascorbic acid in laboratory rat. J Environ Biol. 2007; 28(Suppl. 2)377–384
- Antunes LMG, Darin JD, Bianchi MD. Protective effects of vitamin c against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: A dose-dependent study. Pharmacol Res. 2000; 41: 405–411
- Ocak S, Gorur S, Hakverdi S, Celik S, Erdogan S. Protective effects of caffeic acid phenethyl ester, vitamin C, vitamin E and N-acetylcysteine on vancomycin-induced nephrotoxicity in rats. Basic Clin Pharmacol Toxicol. 2007; 100: 328–333
- Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 95: 351–358
- Flohé L, Otting F. Superoxide dismutase assays. Methods Enzymol. 1984; 105: 93–104
- Aebi H. Catalase in vitro. Methods Enzymol. 1984; 105: 121–126
- Chander V, Singh D, Chopra K. Catechin, a natural antioxidant protects against rhabdomyolysis-induced myoglobinuric acute renal failure. Pharmacol Res. 2003; 48: 503–509
- Stefanovic V, Savic V, Vlahovic P, Cvetkovic T, Najman S, Mitic-Zlatkovic M. Reversal of experimental myoglobinuric acute renal failure with bioflavonoids from seeds of grape. Ren Fail. 2000; 22: 255–266
- Chander V, Chopra K. Molsidomine, a nitric oxide donor and L-arginine protects against rhabdomyolysis-induced myoglobinuric acute renal failure. Biochim Biophys Acta. 2005; 1723: 208–214
- Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol. 1986; 250: H822–H827
- Valdivielso JM, López-Novoa JM, Eleno N, Pérez Barriocanal F. Role of glomerular nitric oxide in glycerol-induced acute renal failure. Can J Physiol Pharmacol. 2000; 8: 476–482
- Cross JM, Donald AE, Nuttall SL, Deanfield JE, Woolfson RG, Macallister RJ. Vitamin C improves resistance but not conduit artery endothelial function in patients with chronic renal failure. Kidney Int. 2003; 63: 1433–1442
- Meister A. Glutathione-ascorbic acid antioxidant system in animals. J Biol Chem. 1994; 269: 9397–9400
- Rebouche CJ. Ascorbic acid and carnitine biosynthesis. Am J Clin Nutr. 1991; 54(Suppl. 6)1147S–1152S
- Loots DT, Mienie LJ, Bergh JJ, Van der Schyf CJ. Acetyl-L-carnitine prevents total body hydroxyl free radical and uric acid production induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the rat. Life Sci. 2004; 75: 1243–1253
- Halliwell B. Vitamin C: antioxidant or pro-oxidant in vivo?. Free Rad Res 1996; 25: 439–454
- Halliwell B, Gutteridge JMC. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys. 1996; 246: 501–514
- Anderson D, Phillips BJ, Yu T, Edwards AJ, Ayesh R, Butterworth KR. The effects of vitamin C supplementation on biomarkers of oxygen radical generated damage in human volunteers with ‘low’ or ‘high’ cholesterol levels. Environ Mol Mutagen. 1997; 30: 161–174
- Berger TM, Polidori MC, Dabbagh A, et al. Antioxidant activity of vitamin C in iron-overloaded human plasma. J Biol Chem. 1997; 272: 15656–15660
- Winterbourn CC. Hydroxyl radical production in body fluids: Roles of metal ions, ascorbate and superoxide. Biochem J. 1981; 198: 125–131
- Minetti M, Forte T, Soriani M, Quarisima V, Menditto A, Ferrari M. Iron-induced ascorbate oxidation in plasma as monitored by ascorbate free radical formation: No spin-trapping evidence for the hydroxyl radical in iron-overload plasma. Biochem J. 1992; 282: 459–465
- Retsky KL, Freeman MW, Frei B. Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. Anti- rather than prooxidant activity of vitamin C in the presence of transition metal ions. J Biol Chem. 1993; 268: 1304–1309
- Chen K, Suh J, Carr AC, Morrow JD, Zeind J, Frei B. Vitamin C suppresses oxidative lipid damage in vivo, even in the presence of iron overload. Am J Physiol Endocrinol Metab. 2000; 279: E1406–1412
- Yang M, Collis CS, Kelly M, Diplock AT, Rice-Evans C. Do iron and vitamin C co-supplementation influence platelet function or LDL oxidizability in healthy volunteers?. Eur J Clin Nutr. 1999; 53: 367–374
- Bulduk E, Gönül B, Ozer C. Effects of vitamin C on muscle glycogen and oxidative events in experimental diabetes. Mol Cell Biochem. 2006; 292: 131–137